Literature DB >> 11181007

Effect of indomethacin on gallbladder inflammation and contractility during acute cholecystitis.

H P Parkman1, A N James, R M Thomas, L L Bartula, J P Ryan, S I Myers.   

Abstract

OBJECTIVE: The aim of this study was to determine whether the prostaglandin synthase inhibitor indomethacin reverses the inflammation and abnormal gallbladder contractility that occur after common bile duct ligation (CBDL), a model of acute cholecystitis.
METHODS: Gallbladder muscle contractility was studied in vitro in normal, CBDL, and sham-operated guinea pigs. Animals were treated with saline or indomethacin in vivo. Acetylcholine (ACh) was used to directly contract the muscle and electric field stimulation (EFS) to activate intrinsic nerves. Hematoxylin and eosin-stained slides of muscle strips were scored for inflammation.
RESULTS: CBDL in saline-treated animals increased the inflammation score and decreased gallbladder muscle contractility to ACh and EFS. Indomethacin decreased the inflammation score and partly reversed the smooth muscle contractile response to ACh 6 and 24 h after CBDL, but not at 48 h. Indomethacin did not reverse the CBDL-induced decrease in nerve-evoked contractions.
CONCLUSION: Gallbladder inflammation and contractile dysfunction after CBDL are partly reversed with indomethacin at 6 and 24 h, but not at 48 h. This suggests that, early in the course of CBDL, the inflammation and contractile dysfunction are, in part, prostaglandin-mediated. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181007     DOI: 10.1006/jsre.2001.6082

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Tempol protects the gallbladder against ischemia/reperfusion.

Authors:  Pedro J Gomez-Pinilla; Pedro J Camello; Jesus A F Tresguerres; María José Pozo
Journal:  J Physiol Biochem       Date:  2010-06-23       Impact factor: 4.158

2.  Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease.

Authors:  B Lavoie; B Nausch; E A Zane; M R Leonard; O B Balemba; A C Bartoo; R Wilcox; M T Nelson; M C Carey; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

3.  Cholelithiatic human gallbladders in vitro fail to respond to cholecystokinin but are responsive to carbachol, histamine, or electrical stimulation.

Authors:  Shripad B Deshpande; Narendra K Gupta; Vijay K Shukla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 4.  Smooth muscle function and dysfunction in gallbladder disease.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gerard P vanBerge-Henegouwen
Journal:  Curr Gastroenterol Rep       Date:  2004-04

5.  ATP induces guinea pig gallbladder smooth muscle excitability via the P2Y4 receptor and COX-1 activity.

Authors:  Aaron C Bartoo; Mark T Nelson; Gary M Mawe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-24       Impact factor: 4.052

6.  Enhanced expression of cystathionine β-synthase and cystathionine γ-lyase during acute cholecystitis-induced gallbladder inflammation.

Authors:  Li Zhang; Chenwei Pan; Bin Yang; Yong Xiao; Baoping Yu
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

7.  Plasma Procalcitonin Is Useful for Predicting the Severity of Acute Cholecystitis.

Authors:  Saben Sakalar; Engin Ozakın; Arif Alper Cevik; Nurdan Acar; Serkan Dogan; Filiz Baloglu Kaya; Taylan Kara
Journal:  Emerg Med Int       Date:  2020-01-14       Impact factor: 1.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.